Glenmark Specialty S.A.

Suisse


 
Quantité totale PI 71
Rang # Quantité totale PI 18 864
Note d'activité PI 2,6/5.0    56
Rang # Activité PI 12 948
Classe Nice dominante Produits pharmaceutiques, vétéri...

Brevets

Marques

29 8
3 6
19 0
6
 
Dernier brevet 2024 - Hpk1 inhibitor for use in the tr...
Premier brevet 2014 - Inhaler
Dernière marque 2024 - ONSPRYA
Première marque 2017 - RYALTRIS

Industrie (Classification de Nice)

Derniers inventions, produits et services

2024 P/S Antihistamines, nasal steroids, and nasal spray preparations for treatment of respiratory disorders
Invention Hpk1 inhibitor for use in the treatment of cancer. The present invention relates to a method of t...
P/S Pharmaceutical & medicinal preparations for treatment of psoriasis and skin conditions.
P/S Pharmaceutical and medicinal preparations for treatment of psoriasis and skin conditions.
P/S Pharmaceutical and medicinal preparations for the treatment of psoriasis and skin conditions.
2023 P/S Pharmaceutical preparations for the treatment of psoriasis in human beings; Medicated ointments f...
Invention Treatment of allergic rhinitis using a combination of mometasone and olopatadine. The present in...
Invention Novel nasal spray assembling process. The invention relates to a novel process of assembling nasa...
Invention Dispensing device and pharmaceutical composition for the treatment of rhinitis. A nasal dispensi...
2022 Invention Nebulization composition comprising tiotropium and its method of administration.
P/S Antihistamine, nasal steroid, nasal spray product for treatment of respiratory disorder; Antihist...
Invention Pyrimidine compounds for use as map4k1 inhibitors. The present disclosure is directed to compoun...
Invention Pyrimidine compounds for use as map4k1 inhibitors. The present disclosure is directed to compound...
Invention Treatment of allergic rhinitis using a combination of mometasone and olopatadine. The present inv...
2021 P/S Pharmaceuticals and medicinal preparations being antihistamines, nasal steroids, nasal spray prod...
Invention Polymorphic forms of a ror inhibiting compound and processes for its preparation. The present in...
Invention Polymorphic forms of a rorγ inhibiting compound and processes for its preparation. The present in...
P/S Pharmaceutical preparations for the treatment of respiratory disease and disorder, not for the tr...
P/S Antihistamine, nasal steroid, nasal spray product, namely, nasal spray preparations for treatment...
2020 Invention An inhalable dry powder composition for pulmonary diseases. The present invention relates to an ...
Invention An inhalable dry powder composition for pulmonary diseases. The present invention relates to an i...
Invention Nebulization composition comprising glycopyrrolate and arformoterol. The present invention relate...
Invention Pharmaceutical compositions comprising mupirocin. The present invention relates to a pharmaceutic...
Invention Nebulization composition comprising tiotropium and indacaterol. This disclosure relates to a neb...
Invention Nebulization composition comprising tiotropium and indacaterol. This disclosure relates to a nebu...
2019 Invention Sterile compositions of indacaterol suitable for nebulization. The present invention relates to ...
Invention Sterile compositions of indacaterol suitable for nebulization. The present invention relates to a...
Invention Topical composition comprising mupirocin. The present invention relates to a topical composition ...
Invention Nebulization composition comprising glycopyrrolate and formoterol. The present invention relates ...
Invention Nebulization composition of mometasone. The present invention relates to a sterile pharmaceutical...
Invention Tiotropium inhalation solution for nebulization. The present invention relates to a sterile pharm...
Invention Treatment of allergic rhinitis in pediatric subjects using a combination of mometasone and olopat...
2018 Invention Dispensing device and pharmaceutical composition for the treatment of rhinitis. A nasal dispensin...
Invention Label
2017 Invention Nebulized tiotropium. The present invention relates to therapeutic methods of administering tiotr...
Invention Nebulized tiotropium. The present invention relates to therapeutic methods of administering tiot...
Invention Nebulizable compositions of tiotropium and formoterol. The present disclosure relates to a nebuli...
Invention Stable fixed dose pharmaceutical composition comprising mometasone and olopatadine. The present ...
Invention Stable fixed dose pharmaceutical composition comprising mometasone and olopatadine. The present i...
2016 Invention Inhaler